406 related articles for article (PubMed ID: 29211310)
1. Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers.
Penel N; Coindre JM; Giraud A; Terrier P; Ranchere-Vince D; Collin F; Guellec SLE; Bazille C; Lae M; de Pinieux G; Ray-Coquard IL; Bonvalot S; Cesne ALE; Robin YM; Stoeckle E; Toulmonde M; Blay JY
Cancer; 2018 Mar; 124(6):1179-1187. PubMed ID: 29211310
[TBL] [Abstract][Full Text] [Related]
2. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
[TBL] [Abstract][Full Text] [Related]
3. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX).
Sundby Hall K; Bruland ØS; Bjerkehagen B; Zaikova O; Engellau J; Hagberg O; Hansson L; Hagberg H; Ahlström M; Knobel H; Papworth K; Zemmler M; Goplen D; Bauer HCF; Eriksson M
Eur J Cancer; 2018 Aug; 99():78-85. PubMed ID: 29929092
[TBL] [Abstract][Full Text] [Related]
5. Surgical Resection Margin Classifications for High-grade Pleomorphic Soft Tissue Sarcomas of the Extremity or Trunk After Neoadjuvant Cytotoxic Therapy.
Cates VM; Cates JMM
Am J Surg Pathol; 2019 Jun; 43(6):844-850. PubMed ID: 30932925
[TBL] [Abstract][Full Text] [Related]
6. Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 years.
Basse C; Italiano A; Penel N; Mir O; Chemin C; Toulmonde M; Duffaud F; Le Cesne A; Chevreau C; Maynou C; Anract P; Gouin F; Rios M; Firmin N; Kurtz JE; Kerbrat P; Piperno-Neumann S; Bertucci F; Rosset P; Isambert N; Bompas E; Dubray-Longeras P; Fiorenza F; Le Maignan C; Chaigneau L; Thyss A; Bouché O; Eymard JC; Delcambre Lair C; Adam J; Karanian M; Lebbé C; Dupré A; Meeus P; Brahmi M; Dufresne A; Ducimetière F; Ray-Coquard I; Blay JY
Int J Cancer; 2019 Oct; 145(8):2135-2143. PubMed ID: 30924137
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Perioperative Chemotherapy Timing in Conjunction With Postoperative External-Beam Radiation Therapy on Extremity Soft-Tissue Sarcomas Outcome.
Mahmoud O; Dosch A; Kwon D; Pitcher JD; Conway S; Benedetto P; Fernandez G; Trent J; Temple HT; Wolfson AH
Am J Clin Oncol; 2016 Oct; 39(5):528-34. PubMed ID: 24879472
[TBL] [Abstract][Full Text] [Related]
8. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).
Valentin T; Le Cesne A; Ray-Coquard I; Italiano A; Decanter G; Bompas E; Isambert N; Thariat J; Linassier C; Bertucci F; Bay JO; Bellesoeur A; Penel N; Le Guellec S; Filleron T; Chevreau C
Eur J Cancer; 2016 Mar; 56():77-84. PubMed ID: 26824706
[TBL] [Abstract][Full Text] [Related]
9. Follow-up after primary treatment of soft tissue sarcoma of extremities: impact of frequency of follow-up imaging on disease-specific survival.
Chou YS; Liu CY; Chen WM; Chen TH; Chen PC; Wu HT; Chiou HJ; Shiau CY; Wu YC; Liu CL; Chao TC; Tzeng CH; Yen CC
J Surg Oncol; 2012 Aug; 106(2):155-61. PubMed ID: 22297812
[TBL] [Abstract][Full Text] [Related]
10. [Adjuvant radiation therapy for soft tissue sarcoma of the extremities: analysis of local control according to volume and dose].
Milbéo Y; Kantor G; Laharie H; Lagarde P; Stoeckle E; Bonichon F; Thomas L; Brouste V; Bui BN
Cancer Radiother; 2005 Sep; 9(5):293-303. PubMed ID: 16005654
[TBL] [Abstract][Full Text] [Related]
11. Factors predicting local recurrence, metastasis, and survival in pediatric soft tissue sarcoma in extremities.
Sawamura C; Springfield DS; Marcus KJ; Perez-Atayde AR; Gebhardt MC
Clin Orthop Relat Res; 2010 Nov; 468(11):3019-27. PubMed ID: 20544321
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma.
Vaynrub M; Taheri N; Ahlmann ER; Yao C; Fedenko AN; Allison DC; Chawla SP; Menendez LR
J Surg Oncol; 2015 Feb; 111(2):152-7. PubMed ID: 25175933
[TBL] [Abstract][Full Text] [Related]
13. Forearm soft tissue sarcoma: tumors characteristics and oncologic outcomes following limb salvage surgery.
Baroudi MR; Ferguson PC; Wunder JS; Isler MH; Mottard S; Werier JA; Turcotte RE
J Surg Oncol; 2014 Nov; 110(6):676-81. PubMed ID: 24910319
[TBL] [Abstract][Full Text] [Related]
14. Bone versus soft-tissue sarcomas in the elderly.
Torigoe T; Terakado A; Suehara Y; Kurosawa H; Yazawa Y; Takagi T
J Orthop Surg (Hong Kong); 2010 Apr; 18(1):58-62. PubMed ID: 20427836
[TBL] [Abstract][Full Text] [Related]
15. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Bramwell V; Rouesse J; Steward W; Santoro A; Schraffordt-Koops H; Buesa J; Ruka W; Priario J; Wagener T; Burgers M
J Clin Oncol; 1994 Jun; 12(6):1137-49. PubMed ID: 8201375
[TBL] [Abstract][Full Text] [Related]
17. Soft tissue sarcoma in children, adolescents and young adults: Outcomes according to compliance with international initial care guidelines.
Collignon C; Carton M; Brisse HJ; Pannier S; Gauthier A; Sarnacki S; Tiléa B; Savignoni A; Helfre S; Philippe-Chomette P; Cardoen L; Boccara O; Pierron G; Orbach D
Eur J Surg Oncol; 2020 Jul; 46(7):1277-1286. PubMed ID: 31839437
[TBL] [Abstract][Full Text] [Related]
18. What Factors Are Predictive of Outcome in the Treatment of Soft Tissue Sarcomas of the Foot and Ankle?
Houdek MT; Beahrs TR; Wyles CC; Rose PS; Sim FH; Turner NS
Foot Ankle Spec; 2017 Feb; 10(1):12-19. PubMed ID: 27587379
[TBL] [Abstract][Full Text] [Related]
19. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma.
Singer S; Corson JM; Gonin R; Labow B; Eberlein TJ
Ann Surg; 1994 Feb; 219(2):165-73. PubMed ID: 8129487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]